CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q1 2023 13F Holders as of 3/31/2023

Type / Class
Equity / NAMEN AKT
Number of holders
372
Total Shares
56.2M
Shares change
+784K
Total reported value, excl. options
$2.54B
Value change
+$38.4M
Put/Call ratio
1.09
Number of buys
141
Number of sells
-166
Price
$45.23
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.